Follow-The-Filings

Security · featured owners

MDLN Medline Inc.

Health Care COM CL A Equity as of 2026 Q2 among managers we track

  • 8 Owners
  • #151
  • Max 9.6%
  • Master 0.13%
  • $2.2B
  • 6 add 2 reduce 2 exits

MDLN (Medline Inc.) is held in 8 featured 13F books as of 2026 Q2. Mala Gaonkar - Surgocap Partners is the largest tracked holder by portfolio weight (9.6%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 9.6% (Mala Gaonkar - Surgocap Partners) · not free-float ownership

  1. Mala Gaonkar add 9.6%
  2. Eric Khrom add 8.1%
  3. John Armitage add 6.3%
  4. Stephen Mandel add 5.1%
  5. Henry Ellenbogen reduce 1.0%
  6. George Soros add 0.79%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Stephen Mandel - Lone Pine Capital 2026 Q2 5.1% Add +77.9% 20,968,367 $827M history
John Armitage - Egerton Capital (UK) 2026 Q2 6.3% Add +277.3% 16,470,884 $650M history
Mala Gaonkar - Surgocap Partners 2026 Q2 9.6% Add +23.2% 7,487,507 $295M history
Andreas Halvorsen - Viking Global Investors 2026 Q2 0.54% Reduce −57.7% 4,841,080 $191M history
Henry Ellenbogen - Durable Capital Partners 2026 Q2 1.0% Reduce −63.8% 2,627,321 $104M history
Eric Khrom - Khrom Capital Management 2026 Q2 8.1% Add +246.4% 2,435,635 $96M history
George Soros - Soros Fund Management 2026 Q2 0.79% Add +27.3% 1,638,244 $65M history
Davidson Kempner Capital Management 2026 Q2 0.15% Add +337.6% 326,000 $13M history
Lee Ainslie - Maverick Capital exited 2026 Q2 last 2026 Q1 0.41% Exit −0.41% 796,077 $35M history
Ron Baron - Bamco Inc. (Baron Capital) exited 2026 Q2 last 2026 Q1 <0.01% Exit 0.00% 14,000 $623K history

8 current · 2 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 10 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 5.07 Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
424B4 Filing Doc
S-1 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 10 rows shown

Filed Form Detail Links
4 Period Aug 19, 2026 · 2 forms Filing Doc
4 Period Aug 13, 2026 Filing Doc
4 Period Aug 7, 2026 Filing Doc
4 Period Aug 5, 2026 Filing Doc
4 Period Aug 6, 2026 Filing Doc
4 Period Jun 15, 2026 · 8 forms Filing Doc
4 Period Dec 16, 2025 · 3 forms Filing Doc
4 Period Jun 5, 2026 Filing Doc
4 Period May 28, 2026 · 4 forms Filing Doc
4 Period May 21, 2026 · 3 forms Filing Doc

Updated 4 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2025
Revenue $28.43B
Gross profit $7.52B
Gross margin * 26.4%
Net income $1.16B
Net margin * 4.1%

Balance sheet

Metric FY2025
Total current assets $10.68B
Total non-current assets * $27.8B
Total assets $38.48B
Total current liabilities $2.49B
Total non-current liabilities $16.71B
Total equity $10.74B

Cash flow

Metric FY2025
Cash from operations $1.74B
Cash from investing -$474M
Cash from financing $399M
Net change in cash $1.69B

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders